First-in-human phase I clinical trial of a recombinant vesicular stomatitis virus (rVSV)-based preventive HIV-1 vaccine
2012 · Retrovirology · 6 citations
https://doi.org/10.1186/1742-4690-9-s2-p134
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
31
Papers
1.3K
Citations
17
h-index
21
i10-index
Marnie Elizaga is an academic researcher from Fred Hutch Cancer Center. The author has contributed to research in topics: HIV Research and Treatment & vaccines and immunoinformatics approaches & Herpesvirus Infections and Treatments. The author has an h-index of 17, co-authored 27 publications.
ORCID: 0000-0003-3515-1530https://doi.org/10.1186/1742-4690-9-s2-p134
https://doi.org/10.1186/1742-4690-9-s2-o56
Click to start Chat